The Global Asthma and COPD Drugs Market is expected to reach USD 62.32 billion by 2028 from USD 43.19 billion in 2019, growing at a CAGR of 4.2% during the forecast period. Increasing asthma and COPD incidence and prevalence, advances in technology, and the rising senescent population is expected to propel the asthma and COPD drugs market during the forecast period.

Companies Covered: Major Companies profiled in the report which are key players in the global asthma and COPD drugs market are Abbott Laboratories, Astrazeneca, Boehringer Ingelheim, Glaxosmithkline, Merck and Co., Grifols, Novartis AG, Pfizer, Roche Holding AG, and Teva Pharmaceutical.